首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective
【24h】

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

机译:动态护理中的广谱β-内酰胺酶:临床观点

获取原文
获取原文并翻译 | 示例
           

摘要

Extended-spectrum beta-lactamase (ESBL)-producing organisms are emerging as a cause of infection in outpatients in many areas of the world. Most of these involve urinary tract infections caused by Escherichia coli harbouring CTX-M types of ESBLs. Risk-factors for such infections include older age and previous use of quinolones and cephalosporins. Oral alternatives for such infections are limited. These organisms may also cause some community-acquired life-threatening infections, such as bacteraemic urinary tract or intra-abdominal infections. Patients with these infections are at increased probability of receiving inappropriate empirical treatment. More studies addressing the risk-factors and therapeutic options for these infections are needed.
机译:产生广谱β-内酰胺酶(ESBL)的生物正在成为世界许多地区门诊患者感染的原因。这些大多数涉及由带有CTX-M类型的ESBL的大肠杆菌引起的尿路感染。此类感染的风险因素包括年龄较大以及以前使用喹诺酮和头孢菌素。此类感染的口服替代品有限。这些生物还可能引起一些社区获得性威胁生命的感染,例如细菌性尿路感染或腹腔内感染。患有这些感染的患者接受不适当的经验治疗的可能性增加。需要针对这些感染的危险因素和治疗选择进行更多研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号